Amino acid sequence of a cardiotoxin-like basic polypeptide (CLBP) with low cytotoxic activity isolated from the venom of the Formosan cobra (Naja naja atra). 1985

M Takechi, and Y Tanaka, and K Hayashi

A cardiotoxin-like basic polypeptide, designated as CLBP, was isolated from the venom of Naja naja atra by gel filtration on Sephadex G-50 followed by CM-cellulose chromatography. The cytotoxicity toward Yoshida sarcoma cells and lethal toxicity toward mice of CLBP were both one-order lower than those of cardiotoxins and cobrotoxin, respectively. CLBP is a single polypeptide consisting of 61 amino acid residues with four intramolecular disulfide linkages. The amino acid sequence of CLBP shows a high degree of homology with those of cardiotoxins from the same venom, but differs in the 19 to 23 positions.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D004179 Cobra Cardiotoxin Proteins Most abundant proteins in COBRA venom; basic polypeptides of 57 to 62 amino acids with four disulfide bonds and a molecular weight of less than 7000; causes skeletal and cardiac muscle contraction, interferes with neuromuscular and ganglionic transmission, depolarizes nerve, muscle and blood cell membranes, thus causing hemolysis. Cobra Cardiotoxin,Direct Lytic Factors,Cardiotoxin I,Cardiotoxin II,Cardiotoxin VII 4,Cardiotoxin VII2,Cardiotoxin-Like Basic Polypeptide,Cardiotoxins, Elapid,Cobra Cytotoxin Proteins,Cobra Toxin Gamma,Cobra Venom Cardiotoxin D,Cytotoxin-Like Basic Protein (Cobra Venom),Basic Polypeptide, Cardiotoxin-Like,Cardiotoxin Like Basic Polypeptide,Cardiotoxin Proteins, Cobra,Cardiotoxin, Cobra,Cytotoxin Proteins, Cobra,Elapid Cardiotoxins,Lytic Factors, Direct,Polypeptide, Cardiotoxin-Like Basic,Toxin Gamma, Cobra
D004546 Elapid Venoms Venoms from snakes of the family Elapidae, including cobras, kraits, mambas, coral, tiger, and Australian snakes. The venoms contain polypeptide toxins of various kinds, cytolytic, hemolytic, and neurotoxic factors, but fewer enzymes than viper or crotalid venoms. Many of the toxins have been characterized. Cobra Venoms,Elapidae Venom,Elapidae Venoms,Naja Venoms,Cobra Venom,Elapid Venom,Hydrophid Venom,Hydrophid Venoms,King Cobra Venom,Naja Venom,Ophiophagus hannah Venom,Sea Snake Venom,Sea Snake Venoms,Venom, Cobra,Venom, Elapid,Venom, Elapidae,Venom, Hydrophid,Venom, King Cobra,Venom, Naja,Venom, Ophiophagus hannah,Venom, Sea Snake,Venoms, Cobra,Venoms, Elapid,Venoms, Elapidae,Venoms, Hydrophid,Venoms, Naja,Venoms, Sea Snake
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

M Takechi, and Y Tanaka, and K Hayashi
October 1970, Biochemical and biophysical research communications,
M Takechi, and Y Tanaka, and K Hayashi
September 1997, Toxicon : official journal of the International Society on Toxinology,
M Takechi, and Y Tanaka, and K Hayashi
July 1976, FEBS letters,
M Takechi, and Y Tanaka, and K Hayashi
March 1978, International journal of peptide and protein research,
M Takechi, and Y Tanaka, and K Hayashi
October 1989, Biochemistry international,
M Takechi, and Y Tanaka, and K Hayashi
October 1976, Biochemical and biophysical research communications,
M Takechi, and Y Tanaka, and K Hayashi
May 1975, Biochemical and biophysical research communications,
M Takechi, and Y Tanaka, and K Hayashi
February 2020, Bioorganic & medicinal chemistry letters,
M Takechi, and Y Tanaka, and K Hayashi
January 1987, Toxicon : official journal of the International Society on Toxinology,
Copied contents to your clipboard!